United States - English - NLM (National Library of Medicine)

merck sharp & dohme llc - fidaxomicin (unii: z5n076g8yq) (fidaxomicin - unii:z5n076g8yq) - fidaxomicin 200 mg - dificid® is indicated in adult and pediatric patients aged 6 months and older for the treatment of c. difficile -associated diarrhea (cdad). to reduce the development of drug-resistant bacteria and maintain the effectiveness of dificid and other antibacterial drugs, dificid should be used only to treat infections that are proven or strongly suspected to be caused by c. difficile . when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dificid is contraindicated in patients who have known hypersensitivity to fidaxomicin or any other ingredient in dificid [see warnings and precautions (5.1)] . risk summary the limited available data on use of dificid in pregnant women are insufficient to inform any drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes. embryo-fetal

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - fidaxomicin, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; butylated hydroxytoluene; sodium starch glycollate; magnesium stearate; pregelatinised maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - dificid (fidaxomicin) is indicated for the treatment of confirmed clostridium difficile infection (cdi) in adults.

United States - English - NLM (National Library of Medicine)

anazaohealth corporation - bicisate (unii: 3jxf0z0xoi) (bicisate - unii:3jxf0z0xoi) - bicisate 1.35 mg - tc99m bicisate is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed there are no known contraindications for this preparation.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - fidaxomicin (unii: z5n076g8yq) (fidaxomicin - unii:z5n076g8yq) - fidaxomicin 200 mg

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - rifampicin 150 mg isoniazid 75 mg & pyrazinamide… - film-coated tablet - rifampicin bp 150 mg isoniazid bp 75 mg … - antimycobacterials: combinations of drugs for

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - rifampicin 150 mg isoniazid 75 mg ethambutol… - film-coated tablet - rifampicin 150 mg isoniazid 75 mg ethambutol… - antimycobacterials: other drugs for treatment of

Kenya - English - Pharmacy and Poisons Board

svizera labs private limited turma india - rifampicin 150/ isoniazid 75 tablets - orodispersible tablet - rifampicin 150/ isoniazid 75 tablets - various

Kenya - English - Pharmacy and Poisons Board

svizera labs pvt ltd turbhe,navi mumbai - rifampicin 150/ pyrazinamide 400/ isoniazid 75/… - tablet - rifampicin 150/ pyrazinamide 400/ isoniazid 75/… - various

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - rifampicin 60 mg isoniazid 30 mg tablets… - dispersible tablet - rifampicin bp 60 mg isoniazid bp30 mg - antimycobacterials: combinations of drugs for

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road andheri ( east) mumbai - rifampicin 60 mg isoniazid 60 mg dispersible… - dispersible tablet - rifampicin bp 60 mg isoniazid bp 60 mg - antimycobacterials: combinations of drugs for